StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure cash

Cash and short-term investments held at the end of each period.

uniQure's cash was $413.03M at Jun 30, 2026. For fiscal 2025 it was $80.24M, down 50.0% from the year before. Over ten years it grew -9.7% a year on average. The highest annual figure on record is $559.35M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.24M-50.0%
FY2024Dec 31, 2024$160.33M-33.6%
FY2023Dec 31, 2023$241.36M+4.4%
FY2022Dec 31, 2022$231.17M-58.7%
FY2021Dec 31, 2021$559.35M+125.8%
FY2020Dec 31, 2020$247.68M-34.9%
FY2019Dec 31, 2019$380.73M+60.4%
FY2018Dec 31, 2018$237.34M+46.6%
FY2017Dec 31, 2017$161.85M+20.5%
FY2016Dec 31, 2016$134.32M-39.7%
FY2015Dec 31, 2015$222.87M+244.5%
FY2014Dec 31, 2014$64.69M+97.4%
FY2013Dec 31, 2013$32.78M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$413.03M+62.8%
Q1 FY2026Mar 31, 2026$139.99M-35.6%
Q4 FY2025Dec 31, 2025$80.24M-50.0%
Q3 FY2025Sep 30, 2025$597.06M+137.3%
Q2 FY2025Jun 30, 2025$253.78M-11.8%
Q1 FY2025Mar 31, 2025$217.23M-10.6%
Q4 FY2024Dec 31, 2024$160.33M-33.6%
Q3 FY2024Sep 30, 2024$251.63M+9.6%
Q2 FY2024Jun 30, 2024$287.88M-43.9%
Q1 FY2024Mar 31, 2024$243.06M+58.0%
Q4 FY2023Dec 31, 2023$241.36M+4.4%
Q3 FY2023Sep 30, 2023$229.48M-47.9%
Q2 FY2023Jun 30, 2023$513.60M+2.6%
Q1 FY2023Mar 31, 2023$153.85M-70.7%
Q4 FY2022Dec 31, 2022$231.17M-58.7%
Q3 FY2022Sep 30, 2022$440.31M-23.9%
Q2 FY2022Jun 30, 2022$500.52M-26.1%
Q1 FY2022Mar 31, 2022$524.89M+101.2%
Q4 FY2021Dec 31, 2021$559.35M+125.8%
Q3 FY2021Sep 30, 2021$578.46M+107.0%
Q2 FY2021Jun 30, 2021$677.33M+115.5%
Q1 FY2021Mar 31, 2021$260.81M-23.7%
Q4 FY2020Dec 31, 2020$247.68M-34.9%
Q3 FY2020Sep 30, 2020$279.49M-30.7%
Q2 FY2020Jun 30, 2020$314.27M+70.7%
Q1 FY2020Mar 31, 2020$342.03M+63.8%
Q4 FY2019Dec 31, 2019$380.73M+60.4%
Q3 FY2019Sep 30, 2019$403.16M+68.3%
Q2 FY2019Jun 30, 2019$184.10M-29.0%
Q1 FY2019Mar 31, 2019$208.79M+48.3%
Q4 FY2018Dec 31, 2018$237.34M+46.6%
Q3 FY2018Sep 30, 2018$239.55M+169.4%
Q2 FY2018Jun 30, 2018$259.18M+149.0%
Q1 FY2018Mar 31, 2018$140.82M+17.1%
Q4 FY2017Dec 31, 2017$161.85M+20.5%
Q3 FY2017Sep 30, 2017$88.93M-43.6%
Q2 FY2017Jun 30, 2017$104.09M–
Q1 FY2017Mar 31, 2017$120.27M–
Q4 FY2016Dec 31, 2016$134.32M–
Q3 FY2016Sep 30, 2016$157.55M–

More uniQure figures

See a number that looks wrong?